国: オランダ
言語: オランダ語
ソース: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
VENLAFAXINEHYDROCHLORIDE SAMENSTELLING overeenkomend met ; VENLAFAXINE
Sandoz B.V. Veluwezoom 22 1327 AH ALMERE
N06AX16
VENLAFAXINEHYDROCHLORIDE COMPOSITION corresponding to ; VENLAFAXINE
Capsule met verlengde afgifte, hard
AMMONIA (E 527) ; CELLULOSE, MICROKRISTALLIJN (E 460) ; COPOVIDON ; ETHYLCELLULOSE (E 462) ; GELATINE (E 441) ; IJZEROXIDE ROOD (E 172) ; IJZEROXIDE ZWART (E 172) ; MAGNESIUMSTEARAAT (E 470b) ; POVIDON K 90 (E 1201) ; PROPYLEENGLYCOL (E 1520) ; RODE INKT ; SCHELLAK (E 904) ; SILICIUMDIOXIDE (E 551) ; TALK (E 553 B) ; TITAANDIOXIDE (E 171), AMMONIA (E 527) ; CELLULOSE, MICROKRISTALLIJN (E 460) ; COPOVIDON ; ETHYLCELLULOSE (E 462) ; GELATINE (E 441) ; IJZEROXIDE ROOD (E 172) ; IJZEROXIDE ZWART (E 172) ; MAGNESIUMSTEARAAT (E 470b) ; POVIDON K 90 (E 1201) ; PROPYLEENGLYCOL (E 1520) ; RODE INKT ; SCHELLAK (E 904) ; SILICIUMDIOXIDE (E 551) ; TALK (E 553 B) ; TITAANDIOXIDE (E 171),
Oraal gebruik
Venlafaxine
Hulpstoffen: AMMONIA (E 527); CELLULOSE, MICROKRISTALLIJN (E 460); COPOVIDON; ETHYLCELLULOSE (E 462); GELATINE (E 441); IJZEROXIDE ROOD (E 172); IJZEROXIDE ZWART (E 172); MAGNESIUMSTEARAAT (E 470b); POVIDON K 90 (E 1201); PROPYLEENGLYCOL (E 1520); RODE INKT; SCHELLAK (E 904); SILICIUMDIOXIDE (E 551); TALK (E 553 B); TITAANDIOXIDE (E 171);
2018-01-22
Sandoz B.V. Page 1/11 Venlafaxine HCl Sandoz ® 37,5/75/150 mg, harde capsule met verlengde afgifte RVG 120505-120506-120507-120508 1313-V4 1.3.1.3 Bijsluiter Augustus 2020 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT VENLAFAXINE HCL SANDOZ ® 37,5 MG, HARDE CAPSULES MET VERLENGDE AFGIFTE VENLAFAXINE HCL SANDOZ ® 75 MG, HARDE CAPSULES MET VERLENGDE AFGIFTE VENLAFAXINE HCL SANDOZ ® 150 MG, HARDE CAPSULES MET VERLENGDE AFGIFTE VENLAFAXINE HCL SANDOZ ® 225 MG, HARDE CAPSULES MET VERLENGDE AFGIFTE venlafaxine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What [Nationally completed name] is and what it is used for 2. What you need to know before you take [Nationally completed name] 3. How to take [Nationally completed name] 4. Possible side effects 5. How to store [Nationally completed name] 6. Contents of the pack and other information 1. WHAT [NATIONALLY COMPLETED NAME] IS AND WHAT IT IS USED FOR [Nationally completed name] contains the active substance venlafaxine. [Nationally completed name] is an antidepressant that belongs to a group of medicines called serotonin and norepinephrine reuptake inhibitors (SNRIs). This group of medicines is used to treat depression and other conditions such as anxiety disorders. It is thought that people who are depressed and/or anxious have lower levels of serotonin and noradrenaline in the brain. It is not fully understood how antidepressants work, but they may help by increasing the levels of serotonin and noradrenaline in the brain. [Nationally complete 完全なドキュメントを読む
Sandoz B.V. Page 1/23 Venlafaxine HCl Sandoz 37,5/75/150 mg, harde capsules met verlengde afgifte RVG 120505-120506-120507-120508 1311-V5 1.3.1.1 Summary of the Product Characteristics Augustus 2020 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Venlafaxine HCl Sandoz 37,5 mg, harde capsules met verlengde afgifte Venlafaxine HCl Sandoz 75 mg, harde capsules met verlengde afgifte Venlafaxine HCl Sandoz 150 mg, harde capsules met verlengde afgifte Venlafaxine HCl Sandoz 225 mg, harde capsules met verlengde afgifte 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each prolonged-release capsule, hard contains 42.45 mg venlafaxine hydrochloride equivalent to 37.5 mg of venlafaxine. Each prolonged-release capsule, hard contains 84.9 mg venlafaxine hydrochloride equivalent to 75 mg of venlafaxine. Each prolonged-release capsule, hard contains of 169.8 mg venlafaxine hydrochloride equivalent to 150 mg of venlafaxine. Excipients with known effect Each capsule contains 0.4 mg of Sunset Yellow FCF (E 110) and 0.2 mg of Allura Red AC (E 129). Each prolonged-release capsule, hard contains of 254.7 mg venlafaxine hydrochloride equivalent to 225 mg of venlafaxine. Excipient with known effect Each capsule contains 0.02 mg of Carmoisine (E 122). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Prolonged-release capsule, hard. Light grey opaque/peach opaque, hard gelatin capsules of approximately 16 mm having thick and thin radial circular band in red ink on the body and the cap. The capsule is filled with 3 white to off-white, round, biconvex, film-coated mini tablets of 12.5 mg each. Peach opaque/peach opaque hard gelatin capsules of approximately 19 mm having thick and thin radial circular band in red ink on the body and the cap. The capsule is filled with 6 white to off white, round, biconvex, film coated mini tablets of 12.5 mg each. Dark orange/dark orange opaque hard gelatin capsules of approximately 21 mm having thick and thin radial circular band in white ink on the body and the cap 完全なドキュメントを読む